These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. AGGRAVATING EFFECT OF ARTERIAL HYPERTENSION ON THE COURSE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN PATIENTS WITH COMORBID PATHOLOGY. Rodionova VV; Boiko OO Wiad Lek; 2021; 74(4):973-976. PubMed ID: 34156014 [TBL] [Abstract][Full Text] [Related]
3. COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare members. Pasquale MK; Xu Y; Baker CL; Zou KH; Teeter JG; Renda AM; Davis CC; Lee TC; Bobula J Int J Chron Obstruct Pulmon Dis; 2016; 11():111-21. PubMed ID: 26834468 [TBL] [Abstract][Full Text] [Related]
4. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients. Kawamatawong T; Onnipa J; Suwatanapongched T Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of therapy efficiency in patients with combined course of copd and osteoarthritis]. Хайменова ГС; Шилкина ЛН; Бабанина МЮ; Волченко ГВ; Ткаченко МВ; Ждан ВН Wiad Lek; 2016; 69(2 Pt 2):214-8. PubMed ID: 27487536 [TBL] [Abstract][Full Text] [Related]
6. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment. Mittal R; Chhabra SK COPD; 2017 Feb; 14(1):1-6. PubMed ID: 27723367 [TBL] [Abstract][Full Text] [Related]
7. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial. Beeh KM; Beier J; Candler H; Wittig T Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515 [TBL] [Abstract][Full Text] [Related]
8. [MECHANISMS OF OSTEOPENIC SYNDROME IMPLEMENTATION IN PATIENTS WITH COMORBIDITY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND CHRONIC PANCREATITIS]. Zhelezniakova N Georgian Med News; 2016 Oct; (259):26-31. PubMed ID: 27845282 [TBL] [Abstract][Full Text] [Related]
9. Clinical Features of Patients with Bronchiectasis with Comorbid Chronic Obstructive Pulmonary Disease in China. Xie C; Wen Y; Zhao Y; Zeng S; Guo Q; Liang Q; Chen L; Liu Y; Qiu F; Yang L; Lu J Med Sci Monit; 2019 Sep; 25():6805-6811. PubMed ID: 31503552 [TBL] [Abstract][Full Text] [Related]
10. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease. Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N; Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740 [TBL] [Abstract][Full Text] [Related]
11. Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort. Lee JY; Chon GR; Rhee CK; Kim DK; Yoon HK; Lee JH; Yoo KH; Lee SH; Lee SY; Kim TE; Kim TH; Park YB; Hwang YI; Kim YS; Jung KS J Korean Med Sci; 2016 Apr; 31(4):553-60. PubMed ID: 27051239 [TBL] [Abstract][Full Text] [Related]
13. Comparison of symptom and risk assessment methods among patients with chronic obstructive pulmonary disease. Zhang R; Tan X; He Q; Chen Q; Gai J; Wei J; Wang Y Chin Med J (Engl); 2014; 127(14):2594-8. PubMed ID: 25043073 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013. Raluy-Callado M; Lambrelli D; MacLachlan S; Khalid JM Int J Chron Obstruct Pulmon Dis; 2015; 10():925-37. PubMed ID: 25999708 [TBL] [Abstract][Full Text] [Related]
15. The effect of comorbidities on COPD assessment: a pilot study. Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbations. Jones PW; Nadeau G; Small M; Adamek L Respir Med; 2014 Jan; 108(1):129-35. PubMed ID: 24041746 [TBL] [Abstract][Full Text] [Related]
17. [The importance of the at risk COPD patients (Stage 0) and clinical differences]. Kömüs N; Tertemiz KC; Sevinç C Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073 [TBL] [Abstract][Full Text] [Related]
18. Characteristics and risk factors for inconsistency between the risk of exacerbations and the severity of airflow limitation in COPD based on GOLD 2017: A retrospective, cross-sectional study. Huang WC; Wu MF; Chen HC; Hsu JY; PLoS One; 2018; 13(3):e0193880. PubMed ID: 29529075 [TBL] [Abstract][Full Text] [Related]
19. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Burgel PR; Nesme-Meyer P; Chanez P; Caillaud D; Carré P; Perez T; Roche N; Chest; 2009 Apr; 135(4):975-982. PubMed ID: 19017866 [TBL] [Abstract][Full Text] [Related]
20. [Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease]. Sleszycka J; Woźniak K; Banaszek M; Wiechno W; Domagała-Kulawik J Pol Merkur Lekarski; 2009 Aug; 27(158):92-6. PubMed ID: 19856871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]